The American Red Cross is making an urgent call for blood and platelet donors to book an appointment to give now to ensure hospitals stay ready to help patients without ...
The American Red Cross is making an urgent call for blood and platelet donors to book an appointment to give now to ensure hospitals stay ready to help patients without ...
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced today that the U.S. Food and Drug Administration (FDA) has approved expanded use of CASGEVY ® (exagamglogene autotemcel) for the treatment ...
The American Red Cross is making an urgent call for blood and platelet donors to book an appointment to give now to ensure hospitals stay ready to help patients without delay. As people get ready for ...
Recently, the NDA for Sumecigrel Capsule (formerly known as Vicagrel), a Class 1 innovative antiplatelet drug developed by ...
American Red Cross is making an urgent call for blood and platelet donors to book an appointment to give now to ensure ...
The American Red Cross is making an urgent call for blood and platelet donors to book an appointment to give now to ensure ...
Selection highlights the clinical value potential of Cadrenal’s first-in-class 12-lipoxygenase inhibitor for Heparin-Induced Thrombocytopenia (HIT) ...
Aplagon, a clinical-stage biotech developing first-in-class therapies for thromboinflammatory diseases, today announced the ...
Gen Z, this will smart. The generation born between 1997 and 2010 is the very first generation who did worse in school than the generation before them, according to a top neuroscientist. And ...
As Generation Z — those born between 1997 and 2012 — enters the workforce in growing numbers, Canadian employers are encountering a cohort whose expectations and behaviours signal a fundamental shift ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results